#Wegovy #NovoNordisk #ObesityTreatment
www.nasdaq.com
FDA Approves Novo Nordisk's Higher-Dose Wegovy for Obesity Patients
Novo Nordisk NVO announced that the FDA has approved Wegovy HD (once-weekly injectable semaglutide 7. 2 mg) to reduce excess body weight and maintain weight reduction in the long term.
B
#MentalHealth #DiabetesTreatment #ObesityManagement
www.bloomberg.com
Study Shows Ozempic Is Linked to Lower Risk of Worsening Mental Health Issues
Swedish people with depression and anxiety who took Novo Nordisk A/S's blockbuster shots Ozempic and Wegovy were less likely to see their mental health get worse, the latest data to suggest that popular diabetes and obesity drugs could also have a broader impact on well-being.
#ObesityTreatment #EyeHealth #GLP1Agonists
nypost.com
Which GLP-1 drug has the highest risk of sudden sight loss and 'eye...
The results of this obesity medication are literally eye-popping.
A new review of adverse effects reports to the FDA between the years 2017 and 2024 reveals that Ozempic and Wegovy have both been linked to dozens of cases of ischemic optic neuropathy (ION), or sudden vision loss caused by restricted blood flow to the optic nerve.
H
#CardiovascularHealth #ObesityManagement #GLP1
health.usnews.com
GLP-1 Drugs for Heart Health: Benefits, Side Effects & Who Should Take Them
Cardiologists and obesity medicine physicians alike are hopeful about these preliminary findings. However, lifestyle habits, including getting adequate sleep, eating healthy and exercising, are still the top ways to stave off cardiovascular disease.
#ObesityTreatment #WeightLoss #FDAApproval
www.yahoo.com
FDA approves Allurion's PMA application for Gastric Balloon System
Allurion's founder and CEO Dr Shantanu Gaur stated that the Smart Capsule offers a safe and effective alternative to GLP-1s and bariatric surgery, aiming to provide metabolically healthy weight loss and become a standard tool in obesity treatment in the US.
#EliLilly #Zepbound #ObesityTreatment
www.cnbc.com
Eli Lilly launches new form of obesity drug Zepbound with a month's worth of doses in one pen
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York on March 28, 2024.
Eli Lilly on Monday launched a new form of its blockbuster obesity drug, Zepbound, that offers a month's worth of doses in a single pen.
#Obesity #HealthInnovation #PersonalizedMedicine
www.forbes.com
How GLP-1 Weight Loss Drugs Have Revolutionized Obesity- Lessons Learned
The blockbuster weight loss GLP-1 drugs such as Wegovy and Zepbound have revolutionized obesity, the way healthcare workers and patients think about the disease and the way it is treated.
#Obesity #HealthInnovation #PersonalizedMedicine
www.forbes.com
How GLP-1 Weight Loss Drugs Have Revolutionized Obesity- Lessons Learned
The blockbuster weight loss GLP-1 drugs such as Wegovy and Zepbound have revolutionized obesity, the way healthcare workers and patients think about the disease and the way it is treated.
#HealthInsurance #GLP1 #ObesityTreatment
news.harvard.edu
Pricey blockbuster GLP-1s are costing users -- and most of the rest of us, too -- Harvard Gazette
Health insurers are passing along cost for coverage in form of higher rates across the board, policy researcher says
The popularity of pricey GLP-1 drugs has hit the budgets of users -- and just about everyone else.
